ArticleCancers2021

Kinome-Wide siRNA Screening Identifies DYRK1B as a Potential Therapeutic Target for Triple-Negative Breast Cancer Cells.

Chia-Che Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.